Verified stock metrics
Relmada Therapeutics, Inc. Key Stock Metrics
Relmada Therapeutics, Inc. (RLMD) market cap, valuation, profitability and grow…
Direct answer
Relmada Therapeutics, Inc. has 6 verified key metrics available.
Market capitalization, valuation, profitability and growth facts share the same observation time.
Only reported values are shown. Missing values are not estimated.
Market data checked August 9, 2026.
Get free Relmada Therapeutics, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Market capitalization
- $526.95M
- Price-to-book ratio
- 0.49x
- Return on equity
- -25.62%
- 52-week price range
- $0.55 to $8.00
- Profit margin
- 0%
- Debt-to-equity ratio
- 0.1%
Explore related company data
View Relmada Therapeutics, Inc.'s market capitalizationView Relmada Therapeutics, Inc.'s price-to-book ratioView Relmada Therapeutics, Inc.'s return on equityView Relmada Therapeutics, Inc.'s 52-week price rangeView Relmada Therapeutics, Inc.'s profit marginView Relmada Therapeutics, Inc.'s debt-to-equity ratioReturn to Relmada Therapeutics, Inc. profile